Observational Study on the Clinical Profile of patients with Uncontrolled Severe Asthma Treated with Tezepelumab in Italy

Trial Identifier: D5180R00031
Sponsor: AstraZeneca
Start Date: June 2025
Primary Completion Date: May 2027
Study Completion Date: May 2027
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy Aosta, Italy
Italy Avellino, Italy
Italy Bari, Italy
Italy Bergamo, Italy
Italy Brescia, Italy
Italy Cagliari, Italy
Italy Catania, Italy
Italy Catanzaro, Italy
Italy Civitanova Marche, Italy
Italy Ferrara, Italy
Italy Foggia, Italy
Italy Genova, Italy
Italy Lamezia Terme, Italy
Italy Massa Carrara, Italy
Italy Milano, Italy
Italy Modena, Italy
Italy Napoli, Italy
Italy Orbassano (TO), Italy
Italy Padova, Italy
Italy Reggio Calabria, Italy
Italy Reggio Emilia, Italy
Italy Roma, Italy
Italy Salerno, Italy
Italy Sassari, Italy
Italy Torino, Italy
Italy Tradate (VA), Italy
Italy Verona, Italy
Italy, Milano Garbagnate Milanese, Milano, Italy
Italy, Padova Cittadella, Padova, Italy
Italy, TV Montebelluna, TV, Italy